Jose Oneto is the founder of Shasqi. Shasqi has raised $60M in total funding. Latest round: Series A. Backed by Y Combinator. Based in San Francisco, CA.
José M. Mejía Oneto, MD PhD, is a physician-scientist with training in orthopedic surgery and organic chemistry. He is the founder and CEO of Shasqi, where he leads the development of the CAPAC platform which uses click chemistry to deliver oncology therapies to tumor sites. Oneto has advanced the company's lead asset SQ3370 into Phase 2 clinical trials for solid tumors.
Full founder directory · Investor directory · Company funding database · Fundraising library